Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

The short- and long-term outcomes of pancreaticoduodenectomy for distal cholangiocarcinoma

P. Skalicky, O. Urban, J. Ehrmann, H. Svebisova, D. Klos, J. Tesarikova, C. Neoral, K. Knapkova, M. Lovecek

. 2022 ; 166 (4) : 386-392. [pub] 20210810

Language English Country Czech Republic

Document type Journal Article

BACKGROUND: The aim of the study was to calculate the short-term and long-term outcomes of curative-intent surgery in distal cholangiocarcinoma (DCC) patients to identify potential prognostic factors. PATIENTS AND METHODS: A retrospective cohort study of 32 consecutive DCC patients treated with pancreaticoduodenectomy between 2009-2017. The clinicopathological and histopathological data were evaluated for prognostic factors using the univariable Cox regression analysis. The Overall Survival (OS) was estimated using the Kaplan-Meier analysis. RESULTS: The study comprised a total of 32 patients, with a mean age of 65.8 (± 9.0) years at the time of surgery. R0 resection was achieved in 25 (86.2%) patients, 19 (65.5%) patients received adjuvant oncological therapy. The OS rates at 1, 3 and 5 years were 62.5%, 37.5% and 21.9%, respectively. The 90-day mortality was 3/32 (9.4%) accounting for one-fourth of the first-year mortality rate. The median OS was 28.5 months. The only statistically significant prognostic factor was vascular resection, which was associated with worse OS in the univariable analysis (HR: 3.644; 95%-CI: 1.179-11.216, P=0.025). An age less than 65 years, ASA grade I/II, hospital stay of fewer than 15 days, R0 resection, lymph node ratio less than 0.2 and adjuvant oncological therapy tended to be associated with better OS but without statistically significant relevance. CONCLUSION: The main factor directly influencing the survival of DCC patients is surgical complications. Surgical mortality comprises a significant group of patients, who die in the first year following pancreaticoduodenectomy. Vascular resection is the most important negative prognostic factor for long-term survival.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22029538
003      
CZ-PrNML
005      
20230118155254.0
007      
ta
008      
230113s2022 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2021.043 $2 doi
035    __
$a (PubMed)34467956
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Skalický, Pavel $u Department of Surgery I, University Hospital Olomouc, Czech Republic $7 xx0102179
245    14
$a The short- and long-term outcomes of pancreaticoduodenectomy for distal cholangiocarcinoma / $c P. Skalicky, O. Urban, J. Ehrmann, H. Svebisova, D. Klos, J. Tesarikova, C. Neoral, K. Knapkova, M. Lovecek
520    9_
$a BACKGROUND: The aim of the study was to calculate the short-term and long-term outcomes of curative-intent surgery in distal cholangiocarcinoma (DCC) patients to identify potential prognostic factors. PATIENTS AND METHODS: A retrospective cohort study of 32 consecutive DCC patients treated with pancreaticoduodenectomy between 2009-2017. The clinicopathological and histopathological data were evaluated for prognostic factors using the univariable Cox regression analysis. The Overall Survival (OS) was estimated using the Kaplan-Meier analysis. RESULTS: The study comprised a total of 32 patients, with a mean age of 65.8 (± 9.0) years at the time of surgery. R0 resection was achieved in 25 (86.2%) patients, 19 (65.5%) patients received adjuvant oncological therapy. The OS rates at 1, 3 and 5 years were 62.5%, 37.5% and 21.9%, respectively. The 90-day mortality was 3/32 (9.4%) accounting for one-fourth of the first-year mortality rate. The median OS was 28.5 months. The only statistically significant prognostic factor was vascular resection, which was associated with worse OS in the univariable analysis (HR: 3.644; 95%-CI: 1.179-11.216, P=0.025). An age less than 65 years, ASA grade I/II, hospital stay of fewer than 15 days, R0 resection, lymph node ratio less than 0.2 and adjuvant oncological therapy tended to be associated with better OS but without statistically significant relevance. CONCLUSION: The main factor directly influencing the survival of DCC patients is surgical complications. Surgical mortality comprises a significant group of patients, who die in the first year following pancreaticoduodenectomy. Vascular resection is the most important negative prognostic factor for long-term survival.
650    _2
$a lidé $7 D006801
650    _2
$a senioři $7 D000368
650    _2
$a pankreatoduodenektomie $7 D016577
650    12
$a nádory žlučových cest $x chirurgie $x patologie $7 D001650
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a výsledek terapie $7 D016896
650    12
$a cholangiokarcinom $x chirurgie $x patologie $7 D018281
650    _2
$a žlučové cesty intrahepatální $x patologie $7 D001653
650    _2
$a prognóza $7 D011379
655    _2
$a časopisecké články $7 D016428
700    1_
$a Urban, Ondřej, $u Department of Internal Medicine II - Gastroenterology and Geriatrics, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic $d 1965- $7 stk2008428564
700    1_
$a Ehrmann, Jiří, $u Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic $d 1967- $7 jo2003163162
700    1_
$a Švébišová, Hana, $u Department of Oncology, University Hospital Olomouc, Czech Republic $d 1967- $7 ntk2011648828
700    1_
$a Klos, Dušan $u Department of Surgery I, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic $7 xx0081738
700    1_
$a Tesaříková, Jana $u Department of Surgery I, University Hospital Olomouc, Czech Republic $7 xx0228946
700    1_
$a Neoral, Čestmír, $u Department of Surgery I, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic $d 1952- $7 xx0000421
700    1_
$a Knápková, Kateřina $u Department of Surgery I, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic $7 xx0258820
700    1_
$a Loveček, Martin, $u Department of Surgery I, University Hospital Olomouc, Czech Republic $d 1971- $7 xx0078672
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $x 1804-7521 $g Roč. 166, č. 4 (2022), s. 386-392
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34467956 $y Pubmed
910    __
$a ABA008 $b A 1502 $c 958 $y p $z 0
990    __
$a 20230113 $b ABA008
991    __
$a 20230118155248 $b ABA008
999    __
$a ok $b bmc $g 1885634 $s 1180863
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 166 $c 4 $d 386-392 $e 20210810 $i 1804-7521 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK138 $a Pubmed-20230113

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...